Hedge Fund - Octagon Capital Advisors
Celldex Therapeutics Inc. (CLDX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $28,060,481 | 4.48% | 707,526 | $29.41 |
| 2 | 2023 - Q3 (2023-09-30) | $20,912,393 | 3.21% | 759,898 | $31.35 |
| 3 | 2023 - Q2 (2023-06-30) | $25,783,339 | 3.58% | 759,898 | $33.70 |
| 4 | 2023 - Q1 (2023-03-31) | $27,341,130 | 3.93% | 759,898 | $43.15 |
| 5 | 2022 - Q4 (2022-12-31) | $33,935,509 | 5.28% | 761,398 | $35.70 |
| 6 | 2022 - Q3 (2022-09-30) | $21,403,000 | 3.69% | 761,398 | $30.66 |
| 7 | 2022 - Q2 (2022-06-30) | $20,527,000 | 5.47% | 761,398 | $29.04 |
| 8 | 2022 - Q1 (2022-03-31) | $25,933,000 | 5.6% | 761,398 | $31.97 |
| 9 | 2021 - Q4 (2021-12-31) | $29,420,000 | 5.72% | 761,398 | $43.58 |
| 10 | 2021 - Q3 (2021-09-30) | $41,108,000 | 10.12% | 761,398 | $46.92 |
| 11 | 2021 - Q2 (2021-06-30) | $18,773,000 | 3.88% | 561,398 | $27.45 |
| 12 | 2021 - Q1 (2021-03-31) | $11,565,000 | 4.35% | 561,398 | $22.96 |
| 13 | 2020 - Q4 (2020-12-31) | $18,245,000 | 6.32% | 1,041,398 | $18.00 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:15.0000 on 2019-02-11